ライフサイエンスコーパス: MR imaging

1 atio should routinely be reported at cardiac MR imaging.

2 MR imaging and 14 with both mammography and MR imaging.

3 in 9 patients were diagnosed TART on US and MR imaging.

4 Informed consent was obtained for MR imaging.

5 ues were calculated for both mammography and MR imaging.

6 ional MR image and evaluated it in brain PET/MR imaging.

7 with that at gadolinium-enhanced T1-weighted MR imaging.

8 computed tomography (CT) followed by TOF PET/MR imaging.

9 ay affect attenuation correction (AC) in PET/MR imaging.

10 s findings was performed between ZTE and SOC MR imaging.

11 myeloma with precision comparable to that of MR imaging.

12 g and contrast material-enhanced T1-weighted MR imaging.

13 ZTE imaging of osseous features exceeded SOC MR imaging.

14 ed or their size can be underestimated at MP MR imaging.

15 s (51.1%; 71 of 139) were detected only with MR imaging.

16 nostic (78 per 1000 vs 85 per 1000, P = .64) MR imaging.

17 se they had additional suspicious lesions at MR imaging.

18 agreement for interpretation of biparametric MR imaging.

19 pons was measured at unenhanced T1-weighted MR imaging.

20 %) and in 72 of 134 targets (53.7%) with 3-T MR imaging.

21 s separately for CE spectral mammography and MR imaging.

22 mammography surveillance in addition to DCE MR imaging.

23 s a screening tool in patients scheduled for MR imaging.

24 amination results, and biopsy results before MR imaging.

25 136 (84%) were correctly identified with MP MR imaging.

26 at multiparametric (MP) magnetic resonance (MR) imaging.

27 were undergoing cardiac magnetic resonance (MR) imaging.

28 nts referred for cardiac magnetic resonance (MR) imaging.

29 em cell transplants with magnetic resonance (MR) imaging.

30 t unenhanced T1-weighted magnetic resonance (MR) imaging.

31 material-enhanced (DCE) magnetic resonance (MR) imaging.

32 n in patients undergoing magnetic resonance (MR) imaging.

33 ogression at posttherapy magnetic resonance (MR) imaging.

34 th a tin filter) and 3-T magnetic resonance (MR) imaging.

35 in patients examined with MR imaging (before MR imaging: 0.13 foci per cell +/- 0.02; 5 minutes after

36 phocytes increased after CT exposure (before MR imaging: 0.14 foci per cell +/- 0.05; 5 minutes after

37 ubjects with DCIS who underwent preoperative MR imaging, 14 experienced recurrence and 11 had an iden

38 ntermediately suspicious via multiparametric MR imaging (31 mutations per sample +/- 15), and high-gr

39 - 19), mildly suspicious via multiparametric MR imaging (37 mutations per sample +/- 21), intermediat

40 nts with IPH at baseline magnetic resonance (MR) imaging (53 carotids with IPH) were randomly selecte

41 nterval: 83.4%, 86.5%) and was high for both MR imaging (97.1%; 95% confidence interval: 96.7%, 97.5%

42 Results Patients underwent MR imaging a mean 12.6 days +/- 5.6 (standard deviation)

43 ymptoms were correlated with the severity of MR imaging abnormalities by using linear regression anal

44 Materials and Methods A PET/MR imaging AC pipeline was built by using a deep learnin

45 Conclusion ATAC in PET/MR imaging achieves similar quantification accuracy to t

46 Seventy-seven patients underwent unenhanced MR imaging after equivocal US findings, yielding an over

47 an activatable molecular magnetic resonance (MR) imaging agent specific for myeloperoxidase (MPO) act

48 Conclusion Biparametric MR imaging allows detection of clinically significant pr

49 s, 12 of 13 incident cancers were found with MR imaging alone (supplemental cancer detection rate, 6.

50 Results MR imaging alone showed true-positive lesions in five pa

51 ere performed for DCIS components visible at MR imaging alone.

52 ts obtained with hepatic magnetic resonance (MR) imaging among readers, imager manufacturers, and fie

53 s in situ) were diagnosed, 43 were seen with MR imaging and 14 with both mammography and MR imaging.

54 E levels between CE spectral mammography and MR imaging and among readers was substantial (kappa = 0.

55 sions classified as PI-RADS category 3 at DW MR imaging and as positive at DCE imaging in the PZ show

56 etrospectively reviewed cancers missed at MP MR imaging and assigned a Prostate Imaging Reporting and

57 ersus full multiparametric contrast-enhanced MR imaging and between-reader agreement for interpretati

58 s performed by using software at T2-weighted MR imaging and contrast material-enhanced T1-weighted MR

59 Significant variance was observed for MR imaging and direct MR arthrography (P < .001) studies

60 DCE MR imaging and FFD mammography combined yielded the high

61 uding biannual AB US, and routine yearly DCE MR imaging and FFD mammography.

62 irect MR arthrography compared with those of MR imaging and indirect MR arthrography.

63 were quantified by using water-fat separated MR imaging and manual segmentations.

64 cts underwent a 3-T resting-state functional MR imaging and static posturography.

65 00 consecutive patients who had undergone MP MR imaging and subsequent radical prostatectomy.

66 T in the residual lesion identified at brain MR imaging and survival time in 56 patients with gliobla

67 mapping between preoperative multiparametric MR imaging and the gland.

68 nclusion Multiregion spatial multiparametric MR imaging and whole-exome radiogenomic analysis of pros

69 Results Radiogenomic multiparametric MR imaging and whole-exome spatial characterization in s

70 nts underwent structural magnetic resonance (MR) imaging and completed cognitive and behavioral tests

71 LS174T-xenografts using magnetic resonance (MR) imaging and fluorescence whole body imaging, which r

72 ze claustrophobia during magnetic resonance (MR) imaging and to explore the potential of the 26-item

73 Screening examinations (magnetic resonance [MR] imaging and mammography) for women at increased brea

74 utes 45 seconds (referred to as biparametric MR imaging), and established a diagnosis according to th

75 rmed on the two main concepts of MR imaging (MR imaging, and direct and indirect MR arthrography) and

76 ean sensitivities of direct MR arthrography, MR imaging, and indirect MR arthrography for SLAP tear d

77 morphology, mass margins at mammography and MR imaging, and nonmass enhancement at MR imaging have t

78 ast agent-enhanced (DCE) magnetic resonance (MR) imaging, and biannual automated breast (AB) ultrason

79 uted tomography (CT) and magnetic resonance (MR) imaging, and the potential effect of reader demograp

80 y and accuracy of breast magnetic resonance (MR) imaging as a supplemental screening tool in women at

81 -art, full multiparametric contrast-enhanced MR imaging at 3.0-T including high-spatial-resolution st

82 -eight additional cancers were detected with MR imaging at initial screening (supplemental cancer det

83 c glucose-enhanced (DGE) magnetic resonance (MR) imaging at 7.0 T.

84 uction error with deep MRAC and two existing MR imaging-based AC approaches with CT-based AC.

85 Conclusion The most accurate MR imaging-based diagnostic criteria for PCOS were OV, F

86 Conclusion This MR imaging-based, semiautomated method provides high rep

87 y and reproducibility of magnetic resonance (MR) imaging-based ovarian morphologic measurements for d

88 onography (US) and other magnetic resonance (MR) imaging-based parameters.

89 a commercially available magnetic resonance (MR) imaging-based, semiautomated method to quantify abdo

90 s performed, followed by T1- and T2-weighted MR imaging before and after gadolinium enhancement.

91 therapy and radiation therapy, who underwent MR imaging before final surgery between June 2011 and Ju

92 with 85 breast cancers who underwent breast MR imaging before neoadjuvant chemotherapy between April

93 ions were observed in patients examined with MR imaging (before MR imaging: 0.13 foci per cell +/- 0.

94 ive dynamic contrast material-enhanced (DCE) MR imaging between 2004 and 2014 with ipsilateral recurr

95 use of radiologic deterioration at follow-up MR imaging between 2006 and 2015.

96 the low versus high BPE groups at diagnostic MR imaging, biopsy recommendation rate was 325 of 1443 v

97 taneously providing increased T1 contrast in MR imaging by concentrating Gd(III) within the nanoparti

98 Novel imaging techniques such as functional MR imaging by using diffusion-weighted MR imaging, MR ly

99 ere investigated with neuromelanin-sensitive MR imaging by using two different 3-T platforms and thre

100 Cardiac MR imaging can evaluate with accuracy a variety of progn

101 sy strategies were further evaluated in each MR imaging category: (a) biopsy with cognitive guidance,

102 resting-state functional magnetic resonance (MR) imaging, cerebellar dentate nuclei (DNs) functional

103 icantly higher for irregular mass margins at MR imaging compared with spiculated mass margins (24.0 v

104 MR imaging confirmed the presence of ischemic lesions as

105 s such as T1-weighted and diffusion-weighted MR imaging could reveal imaging biomarkers associated wi

106 We used diffusion MR imaging data and the Tract-Based Spatial Statistics a

107 t squares algorithm from multiecho spin-echo MR imaging data.

108 y acquired, 3-dimensional spatially resolved MRS imaging data, were compared.

109 mor, whereas gadolinium-enhanced T1-weighted MR imaging demonstrated peripheral contrast enhancement.

110 ed 11 of the 11 secondary cancers (100%) and MR imaging depicted 10 (91%).

111 Screening MR imaging depicted 146 cancers, and 35 interval cancers

112 On a per-patient basis, MP MR imaging depicted clinically important prostate cancer

113 forcement of any a priori assumptions on the MR imaging-derived measurements and with a multivariate

114 Longitudinal T2-weighted MR imaging, dynamic MR spectroscopy of hyperpolarized py

115 uantitative dynamic contrast-enhanced breast MR imaging, even at 1.5 T, to offset significant systemi

116 ver biopsy samples underwent MPO-Gd-enhanced MR imaging ex vivo and subsequent histologic evaluation.

117 glumine (plus a final additional nonenhanced MR imaging examination) were evaluated.

118 e, as well as 5 minutes and 30 minutes after MR imaging examination.

119 ltiparametric diagnostic magnetic resonance (MR) imaging examination followed by MR imaging-guided bi

120 4 volunteers underwent a magnetic resonance (MR) imaging examination in which images were acquired be

121 ents who underwent intravenous GBCA-enhanced MR imaging examinations (55 patients with primary brain

122 thods A total of 121 consecutive whole-spine MR imaging examinations (63 men; mean age +/- standard d

123 ely recruited and underwent two separate 3-T MR imaging examinations 6 months apart.

124 ntification with cardiac magnetic resonance (MR) imaging feature tracking is associated with the seve

125 MR imaging features were compared between patients and c

126 I-RADS) mammographic and magnetic resonance (MR) imaging features and breast cancer recurrence risk i

127 We thus conducted a detailed analysis of the MR imaging findings in 45 HIV- and 11 HIV+ patients to i

128 -up; 1, US follow-up; 2, magnetic resonance (MR) imaging follow-up; and 3, surgical evaluation.

129 medical centers who were undergoing cardiac MR imaging for assessment of LV dysfunction with EF less

130 appears to be more accurate than nonenhanced MR imaging for diagnosis of SLAP tears, whereas 3-T MR i

131 s carried out for utilizing simultaneous PET/MR imaging for five subjects by using the proposed appro

132 sion A staged algorithm of US and unenhanced MR imaging for pediatric appendicitis appears to be effe

133 sk who underwent CE spectral mammography and MR imaging for screening or staging from 2010 through 20

134 The sensitivity of MR imaging for the diagnosis of DCIS components pre-oper

135 ose To assess the use of magnetic resonance (MR) imaging for diagnosis of malignancy in lesions that

136 nctional lung (SENCEFUL) magnetic resonance (MR) imaging for quantitative ventilation (QV) imaging in

137 y conditional unenhanced magnetic resonance (MR) imaging for the imaging work-up of pediatric appendi

138 targeted biopsy and real-time transrectal US-MR imaging fusion biopsy systems.

139 Cardiac MR imaging guided the initiation and withdrawal of antic

140 sonance (MR) imaging examination followed by MR imaging-guided biopsy strategies in the detection of

141 The following three MR imaging-guided biopsy strategies were further evaluat

142 maging/US fusion guidance, and (c) in-gantry MR imaging-guided biopsy.

143 tate free-precession sequences were used for MR imaging-guided catheterization, balloon dilation, and

144 A modified clinical MR imaging-guided focused ultrasound brain system was us

145 se features are evidence of the potential of MR imaging-guided HIFU to be part of a routine strategy

146 The durable clinical efficacy and safety of MR imaging-guided HIFU were demonstrated.

147 -five of the 50 recruited patients underwent MR imaging-guided HIFU.

148 Standard and micro MR imaging guidewires were most suitable for the iliac c

149 y and MR imaging, and nonmass enhancement at MR imaging have the potential to serve as imaging biomar

150 Biparametric MR imaging helped detect clinically significant prostate

151 Conclusion Breast MR imaging improves depiction of DCIS components of inva

152 healthy volunteers underwent phase-contrast MR imaging in a fasting state and again after a standard

153 trong signals were detected in vivo with PET/MR imaging in atherosclerotic plaques of the abdominal a

154 To assess the role of diffusion-weighted MR imaging in differentiation between Graves' disease an

155 ntilation by using dynamic (19)F gas washout MR imaging in free breathing is feasible at 1.5 T even i

156 Conclusion T1rho-weighted DGE MR imaging in healthy volunteers and patients with newly

157 ssels were estimated by using phase-contrast MR imaging in healthy volunteers to allow hemodynamic as

158 rametric contrast material-enhanced prostate MR imaging in men with elevated prostate-specific antige

159 anced US and gadolinium-enhanced T1-weighted MR imaging in nine Seven lesions showed peripheral inhom

160 provides complementary information to CT and MR imaging in the characterization of nodules in high-ri

161 ional MR elastography and diffusion-weighted MR imaging in the determination of fibrosis stage was as

162 l mammography is potentially as sensitive as MR imaging in the evaluation of extent of disease in new

163 ization and segmentation of rectal cancer in MR imaging in the majority of patients.

164 should be preferred over diffusion-weighted MR imaging in the staging of liver fibrosis.

165 by using phase-contrast magnetic resonance (MR) imaging in children and young adults in fasting and

166 ed biparametric prostate magnetic resonance (MR) imaging in comparison with full multiparametric cont

167 was recorded from brain magnetic resonance (MR) imaging in patients with fCCM.

168 l mammography and breast magnetic resonance (MR) imaging in the detection of index and secondary canc

169 trashort echo time (UTE) magnetic resonance (MR) imaging in vivo in order to introduce a new predicto

170 63 years) who underwent magnetic resonance (MR) imaging, including high-b-value DWI and DTI at 3.0 T

171 Diffusion-weighted MR imaging indicated differences in the underlying muscl

172 Between-reader agreement of biparametric MR imaging interpretation was substantial (kappa = 0.81)

173 ancement (BPE) on breast magnetic resonance (MR) imaging interpretive performance in a large multi-in

174 l MAPSE measured during routine cine cardiac MR imaging is a significant independent predictor of mor

175 Conclusion SENCEFUL MR imaging is feasible for QV assessment.

176 In addition, MR imaging is useful to rule out other causes of acute c

177 Conclusion Serial multiparametric MR imaging mapping can be used to evaluate cartilage bey

178 rmine if multiparametric magnetic resonance (MR) imaging mapping can be used to quantify the response

179 sociated with volumetric and microstructural MR imaging markers of subclinical brain damage.

180 Targeted prostate biopsy by using MR imaging may thus help to reduce false-negative result

181 ross-sectional area, echogenicity) and 3.0-T MR imaging measurements (thickness, width, cross-section

182 Voxel-wise R2 and R2* magnetic resonance (MR) imaging measurements were obtained before, immediate

183 MR imaging measures of brain perfusion and metabolism we

184 otherapy doses correlated significantly with MR imaging measures of left ventricular ejection fractio

185 rast-enhancing tumor recurrence at follow-up MR imaging (median, 7.3 months; range, 0.9-46.6 months).

186 ing is a novel diffusion magnetic resonance (MR) imaging method that is able to separate changes affe

187 y is not readily available with contemporary MR imaging methods.

188 ether combining multiple magnetic resonance (MR) imaging modalities such as T1-weighted and diffusion

189 ch was performed on the two main concepts of MR imaging (MR imaging, and direct and indirect MR arthr

190 ional MR imaging by using diffusion-weighted MR imaging, MR lymphography with iron oxide particles, a

191 opancreatography, contrast material-enhanced MR imaging/MR cholangiopancreatography, and ASGE risk st

192 Magnetic resonance (MR) imaging (MRI) is an effective modality for classifyi

193 I: 87, 97] vs 96% [95% CI: 87, 99]; P = .69) MR imaging, nor were there significant differences in ca

194 400 mm(2)/sec, and dynamic contrast-enhanced MR imaging, obtained without endorectal coil within 34 m

195 ively accrued study population who underwent MR imaging of the prostate including transverse T1-weigh

196 Diffusion-weighted MR imaging of the thyroid gland was performed in patient

197 Ferumoxytol-enhanced magnetic resonance (MR) imaging of donor-matched and mismatched stem cell tr

198 Pharma, Berlin, Germany) magnetic resonance (MR) imaging of the abdomen and pelvis was performed at 8

199 rwent dual-energy CT and magnetic resonance (MR) imaging of the axial skeleton.

200 Magnetic resonance (MR) imaging of the brain and the right ankle had been pe

201 aconal masses, for which magnetic resonance (MR) imaging of the orbits was subsequently performed ( F

202 Multiparametric magnetic resonance (MR) imaging of the prostate is more reliably able to loc

203 and zero echo time (ZTE) magnetic resonance (MR) imaging of the shoulder.

204 rodeoxyglucose (FDG) and magnetic resonance (MR) imaging of the upper abdomen.

205 material-enhanced (DCE) magnetic resonance (MR) imaging of transient bone marrow edema syndrome (TBM

206 ponding centers of mass in (18)F-FET PET and MRS imaging of Cho/NAA, determined by simultaneously acq

207 sine ((18)F-FET) and proton MR spectroscopy (MRS) imaging of cell turnover measured by the ratio of c

208 here each of the first 13 subjects underwent MR imaging on three separate occasions to determine long

209 evels with neonates who underwent unenhanced MR imaging or CT.

210 of cartilage changes at magnetic resonance (MR) imaging over 48 months in overweight and obese parti

211 valuate whether publication year, functional MR imaging paradigm, magnetic field strength, statistica

212 to determine the diagnostic accuracy of the MR imaging parameters for discriminating between acute a

213 Whole-lung and lobar (129)Xe MR imaging parameters were obtained by using automated s

214 Conclusion DCE MR imaging parameters, especially the time-signal intens

215 ial infarction and are superior to all other MR imaging parameters.

216 n level-dependent (BOLD) magnetic resonance (MR) imaging parameters in normal pregnancies and those c

217 umor subtype and various magnetic resonance (MR) imaging parameters in the assessment of tumor respon

218 distinguished more objectively from a normal MR imaging pattern by adding quantitative diffusion-weig

219 A diffuse MR imaging pattern can be distinguished more objectively

220 ) for the diagnosis of a diffuse (vs normal) MR imaging pattern, whereas an ADC greater than 0.597 x

221 s with MM for the normal, focal, and diffuse MR imaging patterns were 0.360 x 10(-3) mm(2)/sec +/- 0.

222 n coefficients (ADCs) of magnetic resonance (MR) imaging patterns in the bone marrow of patients with

223 For hepatic MR imaging PDFF, intra- and interexamination intraclass

224 erged field of radiogenomics allows specific MR imaging phenotypes to be linked with gene expression

225 Conclusion The modified MR imaging protocol allowed for identification of the ep

226 d in the diagnostic performance of the short MR imaging protocol consisting of only transverse T2-wei

227 ng were tasked to develop a 20-30-minute PET/MR imaging protocol for detection of chemotherapy-induce

228 The standard MR imaging protocol image set contained images from all

229 quency coils, and an optimized gradient-echo MR imaging protocol was used to achieve signal sensitivi

230 uded in the dynamic contrast-enhanced breast MR imaging protocol with a 1.5-T MR imaging system.

231 0.64, 0.89), and for readers of the standard MR imaging protocol, areas under the curve were 0.71-0.7

232 o 0.5 mL for any of the readers of the short MR imaging protocol, with areas under the curve in the r

233 ared with that of a standard multiparametric MR imaging protocol.

234 ance with an alternative magnetic resonance (MR) imaging protocol (sagittal spin-echo Dixon T2-weight

235 mission tomography (PET)/magnetic resonance (MR) imaging protocol for evaluation of the brain, heart,

236 e if a modified clinical magnetic resonance (MR) imaging protocol provides information on the origin

237 % CI: 0.42, 0.68) for the short and standard MR imaging protocols.

238 ative diffusion-weighted imaging to standard MR imaging protocols.

239 ional full multiparametric contrast-enhanced MR imaging protocols.

240 y role and should be included in the routine MR imaging protocols.

241 Conclusion ZTE MR imaging provides "CT-like" contrast for bone.

242 wer cartilage degeneration, as assessed with MR imaging; rates of progression were lower with greater

243 Positive predictive value for MR imaging recalls was 9.3% (95% CI: 6.83%, 12.36%) and

244 Conclusion MR imaging repeatability is better for global texture pa

245 ension underwent cardiac magnetic resonance (MR) imaging, right-sided heart catheterization, and 6-mi

246 In women at average risk for breast cancer, MR imaging screening improves early diagnosis of prognos

247 nvestigate the types of cancer detected with MR imaging screening.

248 te precession (trueFISP) magnetic resonance (MR) imaging sequence featuring sparse data sampling with

249 e language task (P = .02), longer functional MR imaging session times (P < .01), visual presentation

250 sitivity for studies with shorter functional MR imaging session times (P = .03) and relaxed statistic

251 ated volume and average ADC at lobar (129)Xe MR imaging showed correlation with percentage emphysema

252 The average ADC at whole-lung (129)Xe MR imaging showed moderate correlation with PFT results

253 No detectable neural tissue deposition or MR imaging signal was observed in control rats (n = 6).

254 Of 2044 MR imaging studies in the diagnostic group, 1443 were cl

255 obtained, two pretreatment T2-weighted axial MR imaging studies performed prospectively with the same

256 Meta-analyses were performed that compared MR imaging studies to direct MR arthrography studies and

257 , 3-T studies to 1.5-T studies, and low-bias MR imaging studies to low-bias direct MR arthrography st

258 were recruited and underwent 3861 screening MR imaging studies, covering an observation period of 70

259 38-40 unique studies (equal number of CT and MR imaging studies, uniformly distributed LI-RADS catego

260 Differentiated analysis of MR imaging subgroups again revealed no significant chang

261 dded value to yearly FFD mammography and DCE MR imaging surveillance of carriers of the BRCA mutation

262 A clinical 3.0-T MR imaging system was used to generate T1, T1rho, T2, an

263 By using a 3-T MR imaging system, intermediate-weighted turbo spin-echo

264 a blanket with these copper fibers within an MR imaging system, one can create an electrical current

265 nced breast MR imaging protocol with a 1.5-T MR imaging system.

266 time-of-flight (TOF) PET/magnetic resonance (MR) imaging system.

267 Hybrid PET/MR imaging systems may be particularly vulnerable to thi

268 Magnetic resonance (MR) imaging (T1-weighted and diffusion-weighted imaging)

269 Biparametric prostate MR imaging takes less than 9 minutes examination time, w

270 argeted prostate biopsy, including in-gantry MR imaging-targeted biopsy and real-time transrectal US-

271 Between CE spectral mammography and MR imaging, the intrareader agreement ranged from modera

272 ent magnetic resonance (MR) spectroscopy and MR imaging to assess hepatic triglyceride content, aorti

273 haracterization by using magnetic resonance (MR) imaging to discriminate allergic bronchopulmonary as

274 eks and were imaged with a 7.0-T preclinical MR imaging unit at baseline and 1 week after the last CC

275 ons, and, finally, the field strength of the MR imaging unit.

276 fter the procedure by using a 1.5-T clinical MR imaging unit.

277 psy with cognitive guidance, (b) biopsy with MR imaging/US fusion guidance, and (c) in-gantry MR imag

278 MR imaging visibility and mechanical properties were ass

279 The cancer detection rate for MR imaging was 21.8 cancers per 1000 examinations (95% C

280 ed sensitivity and specificity of functional MR imaging was 44% (95% confidence interval [CI]: 14%, 7

281 ostic accuracy of perfusion CT and perfusion MR imaging was 63% (58 of 92) and 75% (69 of 92), respec

282 Breast MR imaging was performed before and after treatment.

283 Absence of late enhancement at posttreatment MR imaging was significantly associated with pCR (area u

284 studies in which contrast material-enhanced MR imaging was used for assessment of mammographic micro

285 Magnetic resonance (MR) imaging was performed a year later to control the pr

286 Sensitivity and specificity of MR imaging were 96% and 78% respectively, and those of m

287 imaging algorithm in which US and unenhanced MR imaging were performed in pediatric patients suspecte

288 Cancers diagnosed with MR imaging were small (median, 8 mm), node negative in 9

289 Ultrasonography (US) and magnetic resonance (MR) imaging were performed.

290 In the interpretation of SRU guidelines with MR imaging when it was an option, proportions of any neo

291 the initial modality followed by unenhanced MR imaging when US findings were equivocal.

292 hted; and dynamic contrast material-enhanced MR imaging with a 3-T imager at a single institution wer

293 r patients undergoing standard-of-care (SOC) MR imaging with concomitant CT were enrolled in this ins

294 ing for diagnosis of SLAP tears, whereas 3-T MR imaging with or without intra-articular contrast mate

295 rove diagnostic accuracy compared with 1.5-T MR imaging with or without intra-articular contrast mate

296 y volunteers underwent functional 1.5-T lung MR imaging with the SENCEFUL imaging approach, in which

297 he NEPTR at preoperative magnetic resonance (MR) imaging with (166 regions) or without (184 regions)

298 not) who underwent brain magnetic resonance (MR) imaging with a mixed fast spin-echo pulse sequence w

299 an brain tissue by using magnetic resonance (MR) imaging with inhaled hyperpolarized xenon 129 ((129)

300 auma who underwent 1.5-T magnetic resonance (MR) imaging within 90 days of knee trauma.